Загрузка...
Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC-DAD
BACKGROUND: Ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak(®)) are the newest medicines approved for use in the treatment of hepatitis C virus (HCV) and are available in tablet form as an oral combination. Specifically, these agents are indicated in the treatment of HCV in patients with ge...
Сохранить в:
| Опубликовано в: : | Chem Cent J |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5214962/ https://ncbi.nlm.nih.gov/pubmed/28101128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13065-016-0232-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|